Tuebingen, Germany

Judith Feucht

This inventor holds 1 USPTO granted patent. Top assignees: Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan Kettering Cancer Center, Millennium Pharmaceuticals Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Judith Feucht. Retrieved from https://idiyas.com/inventor/judith-feucht-78ugucx9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Judith Feucht: Innovator in Chimeric Antigen Receptors

Introduction

Judith Feucht is a notable inventor based in Tuebingen, Germany. She has made significant contributions to the field of immunotherapy, particularly through her work on chimeric antigen receptors.

Latest Patents

Judith holds a patent for "Chimeric Antigen Receptors Targeting CD19 and Use Thereof." This innovation is crucial in the development of targeted therapies for certain types of cancers.

Career Highlights

Throughout her career, Judith has worked with prominent organizations, including Millennium Pharmaceuticals Limited and Memorial Hospital for Cancer and Allied Diseases. Her experience in these institutions has allowed her to advance her research and contribute to the field of cancer treatment.

Collaborations

Judith has collaborated with esteemed colleagues such as Jorge Mansilla-Soto and Isabelle Riviere. These partnerships have enriched her work and expanded the impact of her innovations.

Conclusion

Judith Feucht's contributions to the field of immunotherapy through her patent and collaborations highlight her role as a leading inventor in cancer treatment. Her work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…